Literature DB >> 29540248

Delays in making initial treatment contact after the first onset of mental health disorders in the Argentinean Study of Mental Health Epidemiology.

J C Stagnaro1, A H Cia2, H Vommaro1, S Sustas1, N Vázquez1, E Serfaty3, R C Kessler4, C Benjet5.   

Abstract

AIMS: While there are effective treatments for psychiatric disorders, many individuals with such disorders do not receive treatment and those that do often take years to get into treatment. Information regarding treatment contact failure and delay in Argentina is needed to guide public health policy and planning. Therefore, this study aimed to provide data on prompt treatment contact, lifetime treatment contact, median duration of treatment delays and socio-demographic predictors of treatment contact after the first onset of a mental disorder.
METHODS: The Argentinean Study of Mental Health Epidemiology (EAESM) is a multistage probability sample representative of adults (aged 18+) living in large urban areas of Argentina. A total of 2116 participants were evaluated with the World Mental Health Composite International Diagnostic Interview to assess psychiatric diagnosis, treatment contact and delay.
RESULTS: Projections of cases that will make treatment contact by 50 years taken from a survival curve suggest that the majority of individuals with a mood (100%) or anxiety disorder (72.5%) in Argentina whose disorder persist for a sufficient period of time eventually make treatment contact while fewer with a substance disorder do so (41.6%). Timely treatment in the year of onset is rare (2.6% for a substance disorder, 14.6% for an anxiety disorder and 31.3% of those with a mood disorder) with mean delays between 8 years for mood disorders and 21 years for anxiety disorders. Younger cohorts are more likely to make treatment contact than older cohorts, whereas those with earlier ages of disorder onset are least likely to make treatment contact. Those with anxiety disorders and major depressive disorder are more likely to make treatment contact when they have comorbid disorders, whereas those with substance use disorders are less likely.
CONCLUSIONS: Argentina needs to implement strategies to get individuals with substance use disorders into treatment, and to reduce treatment delays for all, but particularly to target early detection and treatment among children and adolescents.

Entities:  

Keywords:  Common mental disorders; epidemiology; health service research; population survey; psychiatric services

Mesh:

Year:  2018        PMID: 29540248      PMCID: PMC6998935          DOI: 10.1017/S2045796018000094

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  26 in total

1.  The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI).

Authors:  Ronald C Kessler; T Bedirhan Ustün
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

2.  Treatment delay is associated with more episodes and more severe illness staging progression in patients with bipolar disorder.

Authors:  Pedro Domingues Goi; Mireia Vianna-Sulzbach; Leonardo Silveira; Iria Grande; Ines Chendo; Leonardo Almeida Sodré; Keila Maria Mendes Ceresér; Adriane Ribeiro Rosa; Mauricio Kunz; Marcia Kauer-Sant'Anna; Raffael Massuda; Flavio Kapczinski; Clarissa Severino Gama
Journal:  Psychiatry Res       Date:  2015-04-09       Impact factor: 3.222

3.  Treatment Utilization Among Adolescent Substance Users: Findings from the 2002 to 2013 National Survey on Drug Use and Health.

Authors:  Sarah P Haughwout; Thomas C Harford; I-Jen P Castle; Bridget F Grant
Journal:  Alcohol Clin Exp Res       Date:  2016-07-18       Impact factor: 3.455

4.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

5.  Barriers to mental health treatment: results from the WHO World Mental Health surveys.

Authors:  L H Andrade; J Alonso; Z Mneimneh; J E Wells; A Al-Hamzawi; G Borges; E Bromet; R Bruffaerts; G de Girolamo; R de Graaf; S Florescu; O Gureje; H R Hinkov; C Hu; Y Huang; I Hwang; R Jin; E G Karam; V Kovess-Masfety; D Levinson; H Matschinger; S O'Neill; J Posada-Villa; R Sagar; N A Sampson; C Sasu; D J Stein; T Takeshima; M C Viana; M Xavier; R C Kessler
Journal:  Psychol Med       Date:  2013-08-09       Impact factor: 7.723

6.  Social consequences of psychiatric disorders, I: Educational attainment.

Authors:  R C Kessler; C L Foster; W B Saunders; P E Stang
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

7.  Probability and predictors of treatment-seeking for prescription opioid use disorders: a national study.

Authors:  Carlos Blanco; Miren Iza; Robert P Schwartz; Claudia Rafful; Shuai Wang; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2013-01-08       Impact factor: 4.492

8.  Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative.

Authors:  Philip S Wang; Matthias Angermeyer; Guilherme Borges; Ronny Bruffaerts; Wai Tat Chiu; Giovanni DE Girolamo; John Fayyad; Oye Gureje; Josep Maria Haro; Yueqin Huang; Ronald C Kessler; Viviane Kovess; Daphna Levinson; Yoshibumi Nakane; Mark A Oakley Brown; Johan H Ormel; José Posada-Villa; Sergio Aguilar-Gaxiola; Jordi Alonso; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Somnath Chatterji; T Bedirhan Ustün
Journal:  World Psychiatry       Date:  2007-10       Impact factor: 49.548

9.  Stigma- and non-stigma-related treatment barriers to mental healthcare reported by service users and caregivers.

Authors:  Lisa Dockery; Debra Jeffery; Oliver Schauman; Paul Williams; Simone Farrelly; Oliver Bonnington; Jheanell Gabbidon; Francesca Lassman; George Szmukler; Graham Thornicroft; Sarah Clement
Journal:  Psychiatry Res       Date:  2015-06-14       Impact factor: 3.222

Review 10.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

View more
  4 in total

1.  Ten-year course of treated bipolar I disorder: The role of polarity at onset.

Authors:  María Yoldi-Negrete; Ana Fresán-Orellana; Mariana Jiménez-Tirado; Sara Martínez-Camarillo; Lino Palacios-Cruz; Eduard Vieta; Hiram Ortega-Ortiz; Claudia Becerra-Palars; Doris Gutiérrez-Mora; Beatriz Camarena Medellín
Journal:  Brain Behav       Date:  2021-10-09       Impact factor: 2.708

2.  The next pandemic: impact of COVID-19 in mental healthcare assistance in a nationwide epidemiological study.

Authors:  Felipe Ornell; Wyllians Vendramini Borelli; Daniela Benzano; Jaqueline Bohrer Schuch; Helena Ferreira Moura; Anne Orgler Sordi; Felix Henrique Paim Kessler; Juliana Nichterwitz Scherer; Lisia von Diemen
Journal:  Lancet Reg Health Am       Date:  2021-09-03

3.  ENgage YOung people earlY (ENYOY): a mixed-method study design for a digital transdiagnostic clinical - and peer- moderated treatment platform for youth with beginning mental health complaints in the Netherlands.

Authors:  M van Doorn; A Popma; T van Amelsvoort; C McEnery; J F Gleeson; F G Ory; Jaspers M W M; M Alvarez-Jimenez; D H Nieman
Journal:  BMC Psychiatry       Date:  2021-07-23       Impact factor: 3.630

4.  Lifetime treatment of DSM-IV mental disorders in the Saudi National Mental Health Survey.

Authors:  Abdullah S Al-Subaie; Yasmin A Altwaijri; Abdulhameed Al-Habeeb; Lisa Bilal; Amani Almeharish; Nancy A Sampson; Howard Liu; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2020-06-11       Impact factor: 4.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.